204 related articles for article (PubMed ID: 34949837)
1. Identification and mechanism of G protein-biased ligands for chemokine receptor CCR1.
Shao Z; Shen Q; Yao B; Mao C; Chen LN; Zhang H; Shen DD; Zhang C; Li W; Du X; Li F; Ma H; Chen ZH; Xu HE; Ying S; Zhang Y; Shen H
Nat Chem Biol; 2022 Mar; 18(3):264-271. PubMed ID: 34949837
[TBL] [Abstract][Full Text] [Related]
2. Influence of Chemokine N-Terminal Modification on Biased Agonism at the Chemokine Receptor CCR1.
Sanchez J; Lane JR; Canals M; Stone MJ
Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31096719
[TBL] [Abstract][Full Text] [Related]
3. Biased agonism as a mechanism for differential signaling by chemokine receptors.
Rajagopal S; Bassoni DL; Campbell JJ; Gerard NP; Gerard C; Wehrman TS
J Biol Chem; 2013 Dec; 288(49):35039-48. PubMed ID: 24145037
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of chemically synthesized derivatives of the human CC chemokine CCL15/HCC-2, a high affinity CCR1 ligand.
Escher SE; Forssmann U; Frimpong-Boateng A; Adermann K; Vakili J; Sticht H; Detheux M
J Pept Res; 2004 Jan; 63(1):36-47. PubMed ID: 14984572
[TBL] [Abstract][Full Text] [Related]
5. Differential chemokine activation of CC chemokine receptor 1-regulated pathways: ligand selective activation of Galpha 14-coupled pathways.
Tian Y; New DC; Yung LY; Allen RA; Slocombe PM; Twomey BM; Lee MMK; Wong YH
Eur J Immunol; 2004 Mar; 34(3):785-795. PubMed ID: 14991608
[TBL] [Abstract][Full Text] [Related]
6. Analysis of G Protein and β-Arrestin Activation in Chemokine Receptors Signaling.
Vacchini A; Busnelli M; Chini B; Locati M; Borroni EM
Methods Enzymol; 2016; 570():421-40. PubMed ID: 26921957
[TBL] [Abstract][Full Text] [Related]
7. Location bias contributes to functionally selective responses of biased CXCR3 agonists.
Eiger DS; Boldizsar N; Honeycutt CC; Gardner J; Kirchner S; Hicks C; Choi I; Pham U; Zheng K; Warman A; Smith JS; Zhang JY; Rajagopal S
Nat Commun; 2022 Oct; 13(1):5846. PubMed ID: 36195635
[TBL] [Abstract][Full Text] [Related]
8. The chemokine receptor CCR1 is constitutively active, which leads to G protein-independent, β-arrestin-mediated internalization.
Gilliland CT; Salanga CL; Kawamura T; Trejo J; Handel TM
J Biol Chem; 2013 Nov; 288(45):32194-32210. PubMed ID: 24056371
[TBL] [Abstract][Full Text] [Related]
9. Proteolytic activation of alternative CCR1 ligands in inflammation.
Berahovich RD; Miao Z; Wang Y; Premack B; Howard MC; Schall TJ
J Immunol; 2005 Jun; 174(11):7341-51. PubMed ID: 15905581
[TBL] [Abstract][Full Text] [Related]
10. Computational insights into ligand-induced G protein and β-arrestin signaling of the dopamine D1 receptor.
Li H; Urs NM; Horenstein N
J Comput Aided Mol Des; 2023 Jun; 37(5-6):227-244. PubMed ID: 37060492
[TBL] [Abstract][Full Text] [Related]
11. Biased agonists of the chemokine receptor CXCR3 differentially control chemotaxis and inflammation.
Smith JS; Nicholson LT; Suwanpradid J; Glenn RA; Knape NM; Alagesan P; Gundry JN; Wehrman TS; Atwater AR; Gunn MD; MacLeod AS; Rajagopal S
Sci Signal; 2018 Nov; 11(555):. PubMed ID: 30401786
[TBL] [Abstract][Full Text] [Related]
12. Endogenous ligand bias by chemokines: implications at the front lines of infection and leukocyte trafficking.
Zidar DA
Endocr Metab Immune Disord Drug Targets; 2011 Jun; 11(2):120-31. PubMed ID: 21476969
[TBL] [Abstract][Full Text] [Related]
13. Probing Biased Signaling in Chemokine Receptors.
Amarandi RM; Hjortø GM; Rosenkilde MM; Karlshøj S
Methods Enzymol; 2016; 570():155-86. PubMed ID: 26921946
[TBL] [Abstract][Full Text] [Related]
14. Structural and functional analysis of Ccr1l1, a Rodentia-restricted eosinophil-selective chemokine receptor homologue.
Kline JM; Heusinkveld LE; Taranto E; Martin CB; Tomasi AG; Hsu IJ; Cho K; Khillan JS; Murphy PM; Pontejo SM
J Biol Chem; 2021; 296():100373. PubMed ID: 33548230
[TBL] [Abstract][Full Text] [Related]
15. Allosteric coupling and biased agonism in G protein-coupled receptors.
Bock A; Bermudez M
FEBS J; 2021 Apr; 288(8):2513-2528. PubMed ID: 33621418
[TBL] [Abstract][Full Text] [Related]
16. Molecular Mechanisms of Diverse Activation Stimulated by Different Biased Agonists for the β2-Adrenergic Receptor.
Chen J; Liu J; Yuan Y; Chen X; Zhang F; Pu X
J Chem Inf Model; 2022 Nov; 62(21):5175-5192. PubMed ID: 34802238
[TBL] [Abstract][Full Text] [Related]
17. A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity.
Sanchez-Soto M; Verma RK; Willette BKA; Gonye EC; Moore AM; Moritz AE; Boateng CA; Yano H; Free RB; Shi L; Sibley DR
Sci Signal; 2020 Feb; 13(617):. PubMed ID: 32019899
[TBL] [Abstract][Full Text] [Related]
18. [Biased Signaling through G Protein-coupled Receptors].
Kurose H
Yakugaku Zasshi; 2022; 142(10):1091-1101. PubMed ID: 36184444
[TBL] [Abstract][Full Text] [Related]
19. Biased agonists of the chemokine receptor CXCR3 differentially signal through Gα
Zheng K; Smith JS; Eiger DS; Warman A; Choi I; Honeycutt CC; Boldizsar N; Gundry JN; Pack TF; Inoue A; Caron MG; Rajagopal S
Sci Signal; 2022 Mar; 15(726):eabg5203. PubMed ID: 35316095
[TBL] [Abstract][Full Text] [Related]
20. Differential desensitization, receptor phosphorylation, beta-arrestin recruitment, and ERK1/2 activation by the two endogenous ligands for the CC chemokine receptor 7.
Kohout TA; Nicholas SL; Perry SJ; Reinhart G; Junger S; Struthers RS
J Biol Chem; 2004 May; 279(22):23214-22. PubMed ID: 15054093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
